BRIGHTER AB (PUBL) PUBLISHES EU GROWTH PROSPECTUS
Unofficial English translation for information purposes only. If there are differences between the English translation and the Swedish original, the Swedish text will take precedence.
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR FOR AUSTRALIA, HONG KONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, NEW ZEALAND OR OTHER JURISDICTION WHERE THE ANNOUNCEMENT, PUBLICATION OR DISTRIBUTION RELEASE WOULD BE ILLEGAL OR WOULD REQUIRE REGISTRATION OR OTHER ACTION.
The Board of Directors of Brighter AB (publ) ("the Company") has, due to the imminent unit issue of initially approximately SEK 117.8 million announced on January 29, 2021 (the "Unit Issue"), prepared an EU growth prospectus which today on February 5 2021 has been approved and registered by Finansinspektionen (Sweden's financial supervisory authority).
Publication of prospectus
For complete information regarding the Unit Issue, please refer to the EU Growth Prospectus prepared by the Company and today approved and registered by Finansinspektionen. The EU growth prospectus and application forms will be available on the Company's website (www.brighter.se) and Eminova Fondkommission AB's website (www.eminova.se). The prospectus will also be available on Finansinspektionen's website (www.fi.se).
An English version of the EU growth prospectus will follow shortly and be published on Brighter’s website mid next week. For further information regarding the unit issue, please visit:
https://brighter.se/investors/rights-issue-2021/.
For further information, please contact:
Investor Relations
IR@brighter.se
Ann Zetterberg, CFO
+46 708 37 21 23
ann.zetterberg@brighter.se
Christer Trägårdh, Acting CEO
christer.tragardh@brighter.se
Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.